机构：[1]Key Laboratory of Molecular Medicine and Biotherapy, School of Life Science, Beijing Institute of Technology, Beijing, 100081, China[2]Advanced Innovation Center for Human Brain Protection, Capital Medical University, The National Clinical Research Center for Geriatric Disease, Xuanwu Hospital, Capital Medical University, Beijing, China首都医科大学宣武医院
This work was supported by the National Natural Science Foundation
of China under Grant No. 92049102. We thank the Biological and
Medical Engineering Core Facilities of Beijing Institute of Technology
for support. The authors have nothing to disclose.
第一作者机构：[1]Key Laboratory of Molecular Medicine and Biotherapy, School of Life Science, Beijing Institute of Technology, Beijing, 100081, China
通讯作者：
推荐引用方式(GB/T 7714)：
Yan Yan,Aierken Ailikemu,Wang Chunjian,et al.A potential biomarker of preclinical Alzheimer's disease: The olfactory dysfunction and its pathogenesis-based neural circuitry impairments.[J].NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS.2022,132:857-869.doi:10.1016/j.neubiorev.2021.11.009.
APA：
Yan Yan,Aierken Ailikemu,Wang Chunjian,Song Da,Ni Junjun...&Qing Hong.(2022).A potential biomarker of preclinical Alzheimer's disease: The olfactory dysfunction and its pathogenesis-based neural circuitry impairments..NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS,132,
MLA：
Yan Yan,et al."A potential biomarker of preclinical Alzheimer's disease: The olfactory dysfunction and its pathogenesis-based neural circuitry impairments.".NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS 132.(2022):857-869
：
心理学